Quest Partners LLC Tyra Biosciences, Inc. Transaction History
Quest Partners LLC
- $1.02 Trillion
- Q2 2025
A detailed history of Quest Partners LLC transactions in Tyra Biosciences, Inc. stock. As of the latest transaction made, Quest Partners LLC holds 73,073 shares of TYRA stock, worth $814,763. This represents 0.07% of its overall portfolio holdings.
Number of Shares
73,073
Previous 29,622
146.68%
Holding current value
$814,763
Previous $275 Million
153.85%
% of portfolio
0.07%
Previous 0.03%
Shares
4 transactions
Others Institutions Holding TYRA
# of Institutions
121Shares Held
55MCall Options Held
25KPut Options Held
5.4K-
Ra Capital Management, L.P. Boston, MA10.6MShares$119 Million2.05% of portfolio
-
Alta Partners Management Company, L.P. Jackson, WY4.08MShares$45.5 Million90.83% of portfolio
-
Nextech Invest Ag4.06MShares$45.2 Million10.51% of portfolio
-
Nextech Invest, Ltd. Zurich, V84.06MShares$45.2 Million8.77% of portfolio
-
Bvf Inc San Francisco, CA3.94MShares$44 Million1.61% of portfolio
About Tyra Biosciences, Inc.
- Ticker TYRA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 41,973,600
- Market Cap $468M
- Description
- Tyra Biosciences, Inc., a preclinical-stage biopharmaceutical company, focuses on developing therapies to overcome tumor resistance and enhance outcomes for patients with cancer. Its lead product candidate is TYRA-300, a selective inhibitor of fibroblast growth factor receptor (FGFR)3 for the treatment of muscle invasive bladder cancer. The comp...